Complete Filing Data
ACHIEVE LIFE SCIENCES, INC. reported Net Income Loss of -$54.65 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ACHIEVE LIFE SCIENCES, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$54.6M | -$39.8M | -$29.8M | -$42.4M | -$33.2M | -$14.7M | -$16.4M | -$12.7M | -$10.6M | -$1.2M | -$828.0K | -$26.2M | -$31.8M | -$21.1M | -$14.7M | -$12.6M | -$5.5M |
| Nonoperating Income Expense | $232.0K | -$758.0K | -$2.6M | -$1.6M | -$58.0K | $20.0K | $133.0K | $126.0K | -$7.0M | -$24.0K | $2.0M | $3.2M | $3.5M | $4.9M | $7.6M | -$839.0K | $117.0K |
| Research And Development Expense | $22.8M | $15.8M | $30.1M | $24.0M | $6.9M | $9.7M | $5.9M | $3.1M | $286.0K | $25.1M | $46.2M | $55.3M | $39.9M | $21.6M | $18.5M | $20.2M | |
| General And Administrative Expense | $16.3M | $11.4M | $10.7M | $9.1M | $7.9M | $6.9M | $6.9M | $3.5M | $1.4M | $11.8M | $10.6M | $9.9M | $7.8M | $6.2M | $5.8M | $4.0M | |
| Other Nonoperating Income Expense | -$36.0K | -$30.0K | -$9.0K | $40.0K | -$75.0K | -$49.0K | -$37.0K | -$45.0K | -$35.0K | -$24.0K | -$64.0K | -$19.0K | $120.0K | $138.0K | $6.0K | $6.0K | $70.0K |
| Comprehensive Income Net Of Tax | -$54.7M | -$39.8M | -$29.8M | -$42.4M | -$16.4M | -$12.7M | -$10.6M | -$1.2M | -$16.8M | -$26.3M | -$31.8M | -$21.1M | -$14.6M | -$12.6M | |||
| Revenues From Collaborative Agreements | $18.2M | $27.1M | $29.9M | $20.1M | $5.5M | $13.6M | $25.5M | ||||||||||
| Other Comprehensive Income Loss Net Of Tax | -$21.0K | $27.0K | -$1.0K | $4.0K | $10.0K | -$21.0K | $6.0K | $1.0K | $31.0K | -$35.0K | |||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $8.0K | $10.0K | -$21.0K | $6.0K | $1.0K | $31.0K | |||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$16.4M | -$12.7M | -$13.6M | -$1.7M | -$21.1M | -$14.7M | -$15.6M | -$2.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$14.4M | -$12.7M | -$12.8M | -$12.5M | -$8.5M | -$6.5M | -$7.1M | -$8.2M | -$9.0M | -$13.1M | -$10.5M | -$7.6M | -$7.2M | -$6.7M | -$11.3M | -$8.0M | -$4.7M | -$3.8M | -$2.9M | -$3.3M | -$3.2M | -$3.7M | -$3.6M | -$5.9M | -$3.6M | -$3.2M | -$2.8M | -$3.0M | -$3.7M | -$6.5M | -$169.0K | -$205.0K | -$486.0K | -$268.0K | -$238.0K | -$242.0K | -$1.7M | -$4.6M | -$6.0M | -$4.5M | -$5.7M | -$4.9M | -$7.0M | -$8.6M | -$6.7M | -$10.1M | -$8.4M | -$6.7M | -$4.1M | -$5.9M | -$4.2M | -$6.9M | -$9.6M | $4.5M | -$6.5M | -$3.0M | -$6.9M | $154.0K |
| Nonoperating Income Expense | $251.0K | -$155.0K | $67.0K | -$46.0K | -$30.0K | -$512.0K | -$536.0K | -$525.0K | -$414.0K | -$438.0K | -$395.0K | -$347.0K | -$36.0K | $2.0K | -$9.0K | -$15.0K | -$3.0K | -$10.0K | -$4.0K | $37.0K | $15.0K | $44.0K | $38.0K | $36.0K | $72.0K | $54.0K | $8.0K | -$8.0K | $42.0K | -$7.0M | -$11.0K | -$8.0K | -$4.0K | -$7.0K | -$7.0K | -$6.0K | $1.8M | $141.0K | -$423.0K | $480.0K | $983.0K | $2.3M | $615.0K | -$707.0K | $359.0K | $561.0K | $976.0K | $1.6M | $2.1M | $2.4M | $1.7M | -$1.4M | -$1.6M | $8.6M | -$1.5M | $2.2M | $53.0K | $7.0K |
| Research And Development Expense | $5.3M | $6.7M | $7.1M | $7.6M | $5.1M | $2.8M | $3.6M | $4.6M | $5.5M | $9.9M | $7.2M | $4.4M | $4.5M | $4.6M | $9.2M | $5.6M | $2.3M | $1.9M | $1.1M | $1.5M | $1.8M | $1.8M | $2.0M | $4.1M | $2.1M | $1.5M | $1.0M | $1.2M | $2.2M | $825.0K | $62.0K | $61.0K | $80.0K | $69.0K | $72.0K | $65.0K | $6.6M | $8.3M | $6.5M | $3.7M | $9.9M | $9.6M | $9.9M | $16.9M | $13.2M | $18.0M | $13.3M | $10.9M | $15.6M | $12.9M | $6.3M | $5.1M | $7.5M | $3.8M | $5.4M | $4.9M | $6.7M | $3.1M |
| General And Administrative Expense | $9.4M | $5.9M | $5.8M | $4.9M | $3.3M | $3.2M | $3.0M | $3.1M | $3.0M | $2.8M | $2.9M | $2.8M | $2.6M | $2.1M | $2.1M | $2.3M | $2.4M | $1.9M | $1.8M | $1.8M | $1.4M | $1.9M | $1.6M | $1.9M | $1.6M | $1.8M | $1.8M | $1.8M | $1.6M | $1.5M | $96.0K | $260.0K | $529.0K | $329.0K | $281.0K | $289.0K | $2.9M | $3.1M | $3.1M | $2.7M | $2.7M | $2.5M | $2.7M | $2.8M | $2.4M | $2.5M | $2.5M | $2.5M | $2.0M | $2.0M | $2.0M | $1.7M | $1.7M | $1.5M | $1.5M | $1.6M | $1.1M | $1.5M |
| Other Nonoperating Income Expense | -$5.0K | -$59.0K | $21.0K | -$8.0K | -$2.0K | -$15.0K | -$17.0K | -$6.0K | -$3.0K | -$30.0K | $5.0K | $6.0K | -$1.0K | -$12.0K | -$23.0K | -$12.0K | -$7.0K | -$5.0K | $4.0K | -$3.0K | -$26.0K | -$7.0K | -$9.0K | -$18.0K | -$7.0K | -$11.0K | -$8.0K | -$7.0K | -$35.0K | $10.0K | -$14.0K | -$7.0K | -$39.0K | -$11.0K | -$4.0K | $2.0K | -$11.0K | $36.0K | $96.0K | -$24.0K | -$6.0K | $23.0K | -$62.0K | $87.0K | -$4.0K | $28.0K | -$7.0K | |||||||||||
| Comprehensive Income Net Of Tax | -$14.4M | -$12.7M | -$12.9M | -$12.4M | -$8.5M | -$6.5M | -$7.1M | -$8.2M | -$2.9M | -$3.3M | -$3.7M | -$3.6M | -$5.9M | -$3.2M | -$2.8M | -$3.0M | -$6.5M | -$167.0K | -$205.0K | -$268.0K | -$6.9M | -$3.7M | -$4.5M | -$6.0M | -$4.5M | -$4.9M | -$7.0M | -$8.6M | -$10.0M | -$8.4M | -$6.7M | -$5.9M | -$4.2M | -$6.9M | -$4.4M | $6.6M | -$3.0M | |||||||||||||||||||||
| Revenues From Collaborative Agreements | $2.9M | $6.0M | $6.7M | $4.0M | $1.4M | $5.7M | $4.8M | $4.9M | $11.7M | $8.6M | $9.9M | $6.3M | $5.1M | $9.8M | $6.6M | $2.4M | $1.3M | $1.2M | $1.2M | $1.9M | $1.2M | $4.9M | $1.7M | |||||||||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax | $6.0K | -$3.0K | -$25.0K | $82.0K | -$11.0K | -$1.0K | $1.0K | -$7.0K | $4.0K | $14.0K | $5.0K | $2.0K | $13.0K | -$4.0K | -$1.0K | -$1.0K | $24.0K | -$15.0K | -$6.0K | $38.0K | -$19.0K | -$74.0K | -$54.0K | |||||||||||||||||||||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $1.0K | -$7.0K | $4.0K | $14.0K | $5.0K | $2.0K | $13.0K | -$4.0K | -$1.0K | -$1.0K | $24.0K | -$15.0K | -$6.0K | $38.0K | ||||||||||||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.2M | -$2.8M | -$3.0M | -$9.4M | -$166.0K | -$329.0K | -$405.0K | $5.9M | $4.2M | -$6.9M | -$4.5M | $6.5M | -$3.0M | -$6.9M | -$2.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $21.5M | $20.9M | -$1.4M | $8.3M | $28.0M | $37.3M | $18.1M | $15.8M | $15.8M | $610.0K | $1.8M | $34.1M | $37.2M | $66.2M | $30.9M | $44.1M | $23.0M | $10.7M |
| Cash And Cash Equivalents At Carrying Value | $20.9M | $12.8M | $15.5M | $24.8M | $43.0M | $35.9M | $16.7M | $9.5M | $5.3M | $15.0K | $27.9M | $14.6M | $18.1M | $28.5M | $23.5M | $62.1M | $7.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $20.9M | $12.8M | $15.6M | $24.8M | $43.1M | $35.9M | $16.7M | $9.6M | $5.6M | $15.0K | $67.0K | |||||||
| Retained Earnings Accumulated Deficit | -$260.2M | -$205.6M | -$165.8M | -$135.9M | -$93.6M | -$60.4M | -$45.7M | -$25.4M | -$12.7M | -$2.1M | -$176.8M | -$160.0M | -$133.7M | -$101.8M | -$80.7M | -$66.1M | ||
| Liabilities Current | $9.1M | $6.7M | $20.8M | $21.6M | $4.6M | $2.9M | $2.9M | $3.3M | $2.0M | $3.1M | $20.7M | $22.2M | $14.9M | $11.6M | $30.8M | $27.5M | ||
| Liabilities And Stockholders Equity | $41.8M | $38.6M | $19.4M | $30.0M | $47.5M | $40.3M | $21.1M | $19.1M | $9.9M | $3.8M | $58.2M | $56.3M | $55.7M | $82.0M | $68.0M | $89.9M | ||
| Liabilities | $20.3M | $17.7M | $20.8M | $21.7M | $19.5M | $3.0M | $3.0M | $3.3M | $2.0M | $3.2M | $20.8M | $22.2M | $18.5M | $15.8M | $37.1M | $45.8M | ||
| Assets Current | $39.9M | $36.5M | $17.0M | $27.3M | $44.6M | $37.0M | $17.3M | $15.5M | $5.9M | $18.0K | $57.3M | $55.8M | $53.9M | $80.2M | $66.9M | $89.3M | ||
| Assets | $41.8M | $38.6M | $19.4M | $30.0M | $47.5M | $40.3M | $21.1M | $19.1M | $9.9M | $3.8M | $58.2M | $56.3M | $55.7M | $82.0M | $68.0M | $89.9M | ||
| Additional Paid In Capital Common Stock | $281.6M | $226.3M | $164.2M | $144.1M | $121.5M | $97.6M | $63.7M | $41.2M | $20.6M | $2.7M | $211.6M | $191.4M | $168.2M | $165.4M | $109.0M | $107.6M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $10.0K | $31.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $5.0K | $5.0K | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | ||
| Common Stock Value | $121.0K | $103.0K | $90.0K | $87.0K | $79.0K | $76.0K | $41.0K | $18.0K | $12.0K | $29.0K | $22.0K | $15.0K | $15.0K | $10.0K | $10.0K | |||
| Accounts Payable Current | $618.0K | $1.7M | $841.0K | $332.0K | $859.0K | $144.0K | $213.0K | $95.0K | $1.3M | $72.0K | $139.0K | $1.3M | ||||||
| Employee Related Liabilities Current | $1.9M | $3.0M | $2.3M | $1.7M | $1.9M | $1.5M | $1.1M | $1.2M | $458.0K | $1.3M | $1.3M | $1.7M | $1.5M | |||||
| Other Accrued Liabilities Current | $351.0K | $403.0K | $348.0K | $584.0K | $304.0K | $748.0K | $438.0K | $1.1M | $641.0K | $863.0K | $500.0K | |||||||
| Accrued Liabilities Clinical Current | $368.0K | $1.1M | $280.0K | $1.7M | $1.4M | $453.0K | $387.0K | $1.2M | $877.0K | $10.0M | $13.5M | $11.3M | ||||||
| Property Plant And Equipment Net | $57.0K | $35.0K | $59.0K | $602.0K | $257.0K | $397.0K | $371.0K | $180.0K | $87.0K | |||||||||
| Prepaid Expense And Other Assets Current | $1.3M | $2.5M | $1.4M | $1.1M | $670.0K | $954.0K | $2.0M | $2.2M | $5.8M | |||||||||
| Other Assets Noncurrent | $187.0K | $187.0K | $118.0K | $309.0K | $37.0K | $273.0K | $1.1M | $1.2M | $509.0K | $513.0K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $8.2M | -$2.8M | -$9.2M | -$18.3M | $7.2M | $19.2M | $7.1M | $4.0M | $5.5M | -$52.0K | $61.0K | |||||||
| Goodwill | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | ||||||||
| Finite Lived Intangible Assets Net | $751.0K | $974.0K | $1.2M | $1.4M | $1.6M | $1.9M | $2.1M | $2.3M | $2.5M | $2.8M | ||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$19.1M | $6.4M | $13.3M | -$3.5M | -$10.4M | $5.0M | -$38.5M | $54.4M | ||||||||||
| Capital Lease Obligations Current | $11.0K | $27.0K | $52.0K | $236.0K | $1.1M | $1.1M | $1.4M | $1.3M | ||||||||||
| Accounts Receivable Net Current | $7.0K | $9.0K | $14.0K | $5.7M | $8.7M | $714.0K | $449.0K | $1.2M | ||||||||||
| Capital Lease Obligations Noncurrent | $12.0K | $105.0K | $14.0K | $3.5M | $4.3M | $6.3M | $6.7M | |||||||||||
| Restricted Cash And Cash Equivalents Noncurrent | $50.0K | $50.0K | $50.0K | $50.0K | $272.0K | $314.0K | $314.0K | |||||||||||
| Short Term Investments | $5.1M | $20.9M | $24.6M | $57.3M | $36.4M | $61.6M | ||||||||||||
| Operating Lease Liability Current | $61.0K | $55.0K | $63.0K | $58.0K | $69.0K | $92.0K | $203.0K | $11.0K | ||||||||||
| Operating Lease Right Of Use Asset | $64.0K | $119.0K | $66.0K | $123.0K | $64.0K | $146.0K | $329.0K | |||||||||||
| Operating Lease Liability Noncurrent | $5.0K | $66.0K | $6.0K | $69.0K | $4.0K | $77.0K | $159.0K | $12.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $33.6M | $41.7M | $10.3M | $31.4M | $42.3M | $49.5M | $4.0M | $9.7M | $443.0K | $1.0M | $13.2M | $21.4M | $34.7M | $40.9M | $30.1M | $25.7M | $14.5M | $15.0M | $8.1M | $11.5M | $10.2M | $14.2M | $16.4M | $6.1M | $10.7M | $13.1M | $15.9M | $24.4M | $28.2M | $34.2M | $38.8M | $28.2M | $30.0M | $38.9M | $26.5M | $29.6M | $43.5M | $52.7M | $60.3M | $69.8M | $74.7M | $78.1M | $40.0M | $35.2M | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $31.9M | $51.9M | $13.0M | $9.5M | $14.8M | $66.4M | $19.9M | $25.1M | $16.5M | $18.2M | $29.4M | $36.3M | $33.3M | $42.0M | $29.6M | $22.4M | $12.1M | $12.2M | $7.4M | $10.4M | $7.3M | $11.8M | $15.3M | $4.2M | $8.0M | $13.9M | $15.7M | $27.0K | $10.6M | $18.9M | $67.0K | $42.5M | $48.0M | $25.3M | $49.0M | $40.6M | $28.6M | $13.0M | $18.7M | $18.6M | $11.4M | $13.8M | $56.9M | $15.7M | $20.9M | $7.0M | $11.8M | $33.0M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $32.0M | $51.9M | $13.0M | $9.6M | $14.8M | $66.4M | $20.0M | $25.1M | $16.6M | $18.2M | $29.4M | $36.4M | $33.4M | $42.1M | $29.7M | $22.4M | $12.2M | $12.2M | $7.4M | $10.5M | $7.4M | $11.8M | $15.3M | $4.4M | $8.0M | $6.0K | |||||||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$245.6M | -$231.1M | -$218.4M | -$193.2M | -$180.7M | -$172.2M | -$160.3M | -$153.2M | -$144.9M | -$124.7M | -$111.6M | -$101.2M | -$86.4M | -$79.7M | -$68.4M | -$55.7M | -$51.9M | -$49.0M | -$42.5M | -$38.8M | -$31.3M | -$21.7M | -$18.5M | -$15.7M | -$8.9M | -$203.2M | -$200.2M | -$191.1M | -$187.4M | -$180.5M | -$175.1M | -$170.5M | -$164.5M | -$154.3M | -$149.3M | -$142.3M | -$127.0M | -$117.0M | -$108.5M | -$97.7M | -$91.8M | -$87.6M | -$71.2M | -$75.6M | |||||||||||
| Liabilities Current | $9.7M | $8.6M | $7.1M | $6.7M | $13.7M | $20.6M | $4.1M | $3.4M | $20.3M | $6.9M | $5.4M | $4.0M | $3.1M | $4.7M | $3.5M | $1.8M | $1.8M | $1.5M | $3.1M | $3.0M | $4.0M | $3.0M | $2.8M | $2.3M | $2.3M | $1.8M | $2.0M | $10.6M | $13.9M | $14.5M | $29.3M | $35.0M | $16.2M | $20.9M | $20.2M | $16.9M | $14.4M | $12.7M | $11.0M | $21.7M | $27.4M | $31.0M | $19.1M | $27.9M | |||||||||||
| Liabilities And Stockholders Equity | $52.0M | $58.9M | $27.4M | $47.9M | $64.8M | $70.0M | $24.3M | $28.9M | $20.8M | $23.7M | $34.0M | $40.6M | $37.8M | $45.6M | $33.7M | $27.6M | $16.5M | $16.6M | $11.5M | $14.8M | $14.5M | $17.1M | $19.2M | $8.5M | $13.0M | $14.9M | $17.9M | $35.1M | $42.2M | $48.8M | $68.2M | $63.4M | $46.4M | $62.7M | $49.7M | $49.8M | $61.6M | $69.3M | $75.4M | $97.2M | $108.0M | $115.2M | $74.7M | $79.5M | |||||||||||
| Liabilities | $18.4M | $17.3M | $17.1M | $16.5M | $22.5M | $20.6M | $20.3M | $19.2M | $20.4M | $22.7M | $20.8M | $19.2M | $3.1M | $4.7M | $3.6M | $1.9M | $1.9M | $1.7M | $3.4M | $3.3M | $4.3M | $3.0M | $2.8M | $2.3M | $2.3M | $1.8M | $2.0M | $10.7M | $13.9M | $14.6M | $29.5M | $35.2M | $16.4M | $23.8M | $23.3M | $20.2M | $18.1M | $16.6M | $15.1M | $27.4M | $33.3M | $37.1M | $34.7M | $44.3M | |||||||||||
| Assets Current | $50.1M | $56.9M | $25.0M | $45.5M | $62.5M | $67.7M | $21.9M | $26.4M | $18.2M | $21.0M | $31.1M | $37.7M | $34.7M | $42.4M | $30.4M | $24.1M | $12.7M | $12.9M | $7.6M | $10.8M | $10.5M | $13.5M | $15.6M | $4.7M | $8.6M | $14.5M | $17.5M | $34.3M | $41.4M | $48.0M | $67.6M | $62.7M | $45.5M | $61.3M | $47.9M | $48.1M | $59.7M | $67.3M | $73.5M | $95.8M | $104.9M | $114.6M | $74.0M | $78.8M | |||||||||||
| Assets | $52.0M | $58.9M | $27.4M | $47.9M | $64.8M | $70.0M | $24.3M | $28.9M | $20.8M | $23.7M | $34.0M | $40.6M | $37.8M | $45.6M | $33.7M | $27.6M | $16.5M | $16.6M | $11.5M | $14.8M | $14.5M | $17.1M | $19.2M | $8.5M | $13.0M | $14.9M | $17.9M | $35.1M | $42.2M | $48.8M | $68.2M | $63.4M | $46.4M | $62.7M | $49.7M | $49.8M | $61.6M | $69.3M | $75.4M | $97.2M | $108.0M | $115.2M | $74.7M | $79.5M | |||||||||||
| Additional Paid In Capital Common Stock | $279.0M | $272.7M | $228.6M | $224.4M | $222.9M | $221.6M | $164.2M | $162.8M | $145.3M | $125.7M | $124.7M | $122.5M | $121.1M | $120.5M | $98.4M | $81.3M | $66.4M | $64.0M | $50.6M | $50.3M | $41.5M | $35.9M | $34.9M | $21.8M | $19.6M | $213.7M | $213.5M | $212.8M | $213.0M | $212.1M | $211.2M | $196.1M | $191.9M | $190.5M | $173.1M | $169.3M | $167.9M | $167.0M | $166.2M | $164.8M | $163.9M | $163.1M | $108.7M | $108.2M | |||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $9.0K | $3.0K | $6.0K | $75.0K | -$7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $5.0K | $5.0K | $5.0K | $5.0K | $2.6M | $2.6M | $2.6M | $2.7M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.7M | $2.6M | $2.6M | $2.5M | $2.6M | |||||||||||
| Common Stock Value | $121.0K | $118.0K | $103.0K | $103.0K | $103.0K | $103.0K | $90.0K | $90.0K | $87.0K | $79.0K | $79.0K | $79.0K | $79.0K | $79.0K | $76.0K | $74.0K | $51.0K | $43.0K | $19.0K | $19.0K | $18.0K | $16.0K | $15.0K | $13.0K | $11.0K | $30.0K | $30.0K | $29.0K | $30.0K | $29.0K | $30.0K | $30.0K | $24.0K | $22.0K | $21.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $14.0K | $15.0K | $10.0K | $10.0K | ||||||||||
| Accounts Payable Current | $1.9M | $1.2M | $1.7M | $2.0M | $1.0M | $550.0K | $373.0K | $638.0K | $361.0K | $1.1M | $412.0K | $656.0K | $418.0K | $815.0K | $575.0K | $585.0K | $326.0K | $523.0K | $184.0K | $574.0K | $707.0K | $694.0K | $458.0K | $251.0K | $420.0K | $495.0K | $233.0K | $359.0K | $1.0M | $559.0K | $592.0K | $1.8M | $302.0K | $988.0K | $1.6M | $1.3M | $923.0K | $39.0K | $130.0K | ||||||||||||||||
| Employee Related Liabilities Current | $2.4M | $1.6M | $964.0K | $2.3M | $1.3M | $864.0K | $1.7M | $1.2M | $747.0K | $1.4M | $1.1M | $663.0K | $1.2M | $795.0K | $522.0K | $940.0K | $735.0K | $419.0K | $1.2M | $855.0K | $488.0K | $1.1M | $750.0K | $592.0K | $343.0K | $254.0K | $210.0K | $1.0M | $1.4M | $1.3M | $744.0K | $1.6M | $1.3M | $731.0K | $1.1M | $981.0K | $904.0K | $1.4M | |||||||||||||||||
| Other Accrued Liabilities Current | $1.8M | $1.2M | $1.3M | $573.0K | $898.0K | $617.0K | $1.0M | $693.0K | $752.0K | $699.0K | $539.0K | $513.0K | $648.0K | $194.0K | $193.0K | $211.0K | $360.0K | $314.0K | $174.0K | $424.0K | $342.0K | $545.0K | $755.0K | $966.0K | $532.0K | $1.3M | $1.1M | $834.0K | $602.0K | $622.0K | $909.0K | $811.0K | $954.0K | $1.0M | |||||||||||||||||||||
| Accrued Liabilities Clinical Current | $850.0K | $2.0M | $2.0M | $1.7M | $1.7M | $525.0K | $990.0K | $1.0M | $1.4M | $4.6M | $3.0M | $2.2M | $757.0K | $3.0M | $2.1M | $93.0K | $73.0K | $571.0K | $737.0K | $892.0K | $2.1M | $667.0K | $782.0K | $774.0K | $162.0K | $50.0K | $342.0K | $3.4M | $7.1M | $7.7M | $8.5M | $10.0M | $10.5M | $9.7M | |||||||||||||||||||||
| Property Plant And Equipment Net | $21.0K | $27.0K | $33.0K | $42.0K | $50.0K | $56.0K | $52.0K | $64.0K | $71.0K | $80.0K | $32.0K | $42.0K | $18.0K | $94.0K | $129.0K | $166.0K | $258.0K | $493.0K | $534.0K | $546.0K | $380.0K | $406.0K | $416.0K | $312.0K | $354.0K | $349.0K | $443.0K | $496.0K | $437.0K | $223.0K | $226.0K | $161.0K | $198.0K | $207.0K | |||||||||||||||||||||
| Prepaid Expense And Other Assets Current | $1.9M | $1.5M | $1.8M | $2.1M | $2.6M | $1.2M | $1.3M | $1.9M | $958.0K | $1.6M | $2.6M | $1.5M | $1.4M | $1.3M | $430.0K | $802.0K | $1.7M | $545.0K | $746.0K | $264.0K | $356.0K | $866.0K | $933.0K | $1.6M | $1.3M | $1.6M | $1.6M | $2.0M | $3.0M | $2.5M | $2.3M | $1.8M | $2.7M | $3.5M | $3.8M | ||||||||||||||||||||
| Other Assets Noncurrent | $308.0K | $446.0K | $293.0K | $190.0K | $185.0K | $97.0K | $141.0K | $101.0K | $135.0K | $415.0K | $13.0K | $13.0K | $13.0K | $13.0K | $12.0K | $38.0K | $38.0K | $13.0K | $272.0K | $773.0K | $1.3M | $1.1M | $1.2M | $1.2M | $1.2M | $1.1M | $2.9M | $509.0K | $509.0K | $509.0K | |||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $263.0K | $50.8M | -$8.3M | -$6.7M | -$6.2M | -$4.5M | -$2.2M | -$1.1M | $9.0K | ||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | ||||||||||||||||||||||||||||||
| Finite Lived Intangible Assets Net | $807.0K | $863.0K | $918.0K | $1.0M | $1.1M | $1.1M | $1.3M | $1.3M | $1.4M | $1.5M | $1.5M | $1.6M | $1.7M | $1.8M | $1.8M | $1.9M | $2.0M | $2.0M | $2.1M | $2.2M | $2.3M | $2.4M | $2.4M | $2.5M | $2.6M | ||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | $457.0K | -$15.4M | -$2.6M | $14.0M | $553.0K | $28.3M | -$16.5M | ||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Lease Obligations Current | $11.0K | $11.0K | $31.0K | $46.0K | $55.0K | $57.0K | $57.0K | $57.0K | $51.0K | $53.0K | $54.0K | $52.0K | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.5M | $1.4M | $1.4M | $1.4M | $1.4M | ||||||||||||||||||||||||||||||||
| Accounts Receivable Net Current | $8.0K | $25.0K | $124.0K | $7.0K | $70.0K | $241.0K | $237.0K | $478.0K | $13.0K | $149.0K | $1.6M | $4.8M | $5.0M | $8.6M | $9.9M | $6.4M | $5.2M | $1.1M | $956.0K | $774.0K | $987.0K | $1.5M | |||||||||||||||||||||||||||||||||
| Capital Lease Obligations Noncurrent | $15.0K | $18.0K | $16.0K | $22.0K | $32.0K | $49.0K | $67.0K | $84.0K | $92.0K | $117.0K | $130.0K | $128.0K | $2.9M | $3.1M | $3.3M | $3.7M | $3.9M | $4.1M | $5.7M | $5.9M | $6.1M | $6.5M | $6.6M | ||||||||||||||||||||||||||||||||
| Restricted Cash And Cash Equivalents Noncurrent | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $50.0K | $272.0K | $272.0K | $272.0K | $272.0K | $272.0K | $272.0K | $272.0K | $222.0K | $190.0K | $190.0K | $251.0K | $251.0K | $251.0K | $314.0K | ||||||||||||||||||||||||||||||||
| Short Term Investments | $33.4M | $46.6M | $2.3M | $1.4M | $760.0K | $10.2M | $20.7M | $23.5M | $12.2M | $15.1M | $19.2M | $5.1M | $8.9M | $33.8M | $38.2M | $46.0M | $73.7M | $83.8M | $54.5M | $53.5M | $54.5M | ||||||||||||||||||||||||||||||||||
| Operating Lease Liability Current | $59.0K | $58.0K | $57.0K | $22.0K | $37.0K | $53.0K | $61.0K | $60.0K | $58.0K | $23.0K | $41.0K | $59.0K | $69.0K | $68.0K | $67.0K | $129.0K | $165.0K | $196.0K | $198.0K | $176.0K | $170.0K | ||||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $79.0K | $93.0K | $106.0K | $20.0K | $35.0K | $51.0K | $80.0K | $95.0K | $109.0K | $18.0K | $33.0K | $49.0K | $79.0K | $94.0K | $108.0K | $193.0K | $240.0K | $285.0K | $372.0K | $414.0K | $455.0K | ||||||||||||||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $21.0K | $37.0K | $52.0K | $22.0K | $38.0K | $54.0K | $23.0K | $41.0K | $59.0K | $94.0K | $110.0K | $118.0K | $212.0K | $243.0K | $289.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $51.5M | $48.5M | $15.3M | $19.3M | $36.6M | $32.7M | $17.3M | $19.8M | $2.0M | $150.0K | $2.4M | $25.2M | $10.0K | $54.2M | $219.0K | $47.5M | $17.3M |
| Investing Cash Flow * | $6.1M | -$21.6M | -$21.0K | -$17.0K | $5.0M | -$5.1M | $12.6M | $10.6M | -$2.0M | $5.4M | $32.4M | -$21.2M | $25.1M | -$59.1M | $2.2M | ||
| Operating Cash Flow * | -$49.5M | -$29.8M | -$24.5M | -$37.6M | -$29.4M | -$13.5M | -$15.2M | -$10.6M | -$9.1M | -$202.0K | -$350.0K | -$17.3M | -$35.9M | -$43.5M | -$20.3M | -$26.8M | $34.9M |
| Share Based Compensation | $8.8M | $5.3M | $3.4M | $3.3M | $2.2M | $1.3M | $1.2M | $854.0K | $348.0K | $1.6M | $2.3M | $3.9M | $2.8M | $2.2M | $1.2M | $642.0K | $380.0K |
| Increase Decrease In Accounts Payable Trade | $1.3M | -$1.0M | $799.0K | $509.0K | -$527.0K | $715.0K | -$69.0K | $118.0K | $22.0K | $57.0K | -$67.0K | -$1.2M | -$175.0K | $1.2M | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $765.0K | -$1.2M | $931.0K | $228.0K | $452.0K | -$194.0K | $341.0K | $1.3M | $2.0K | -$1.2M | -$3.9M | $2.0M | $3.0M | -$1.3M | |||
| Increase Decrease In Employee Related Liabilities | -$1.1M | $716.0K | $633.0K | -$263.0K | $466.0K | $358.0K | -$52.0K | $710.0K | $458.0K | -$1.1M | -$66.0K | -$372.0K | $164.0K | $589.0K | $855.0K | ||
| Increase Decrease In Lease Obligations | $0.00 | $1.0K | $58.0K | $5.0K | $14.0K | $10.0K | -$10.0K | $4.0K | -$27.0K | $51.0K | -$100.0K | $84.0K | $21.0K | -$33.0K | -$154.0K | ||
| Increase Decrease In Other Accrued Liabilities | $222.0K | -$32.0K | $55.0K | -$245.0K | $280.0K | -$328.0K | $310.0K | -$2.2M | $670.0K | $284.0K | $363.0K | $41.0K | $269.0K | ||||
| Payments To Acquire Property Plant And Equipment | $3.0K | $21.0K | $17.0K | $53.0K | $46.0K | $46.0K | $371.0K | $82.0K | $253.0K | $291.0K | $79.0K | $68.0K | $15.0K | ||||
| Increase Decrease In Accounts Receivable | $1.0K | -$2.0K | $9.0K | $464.0K | -$5.7M | -$3.0M | $7.9M | $265.0K | -$201.0K | -$2.4M | $3.0M | ||||||
| Increase Decrease In Accrued Clinical Liabilities | -$709.0K | $797.0K | -$1.4M | $376.0K | $899.0K | $66.0K | -$812.0K | $322.0K | $877.0K | ||||||||
| Proceeds From Warrant Exercises | $1.4M | $682.0K | $227.0K | $24.0K | $338.0K | $3.2M | $4.2M | $1.3M | |||||||||
| Increase Decrease In Accrued Liabilities | $322.0K | $877.0K | -$6.6M | -$3.7M | $2.2M | $7.6M | $3.4M | $247.0K | |||||||||
| Increase Decrease In Accrued Interest Receivable Net | -$79.0K | -$2.0K | -$105.0K | -$109.0K | -$36.0K | -$211.0K | $494.0K | ||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $0.00 | $114.0K | $220.0K | $47.0K | $5.0K | $2.0K | $52.0K | $29.0K | |||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | -$1.0K | -$1.0K | $9.0K | -$40.0K | -$33.0K | -$21.0K | |||||||||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $47.2M | $21.7M | $24.9M | $63.4M | $82.2M | $87.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $56.1M | $47.0K | $95.0K | $236.0K | -$47.0K | $1.1M | $20.0K | -$52.0K | $30.0K | $10.0K | $53.8M | $91.0K | |||||||||||||||||||||||||||||||||
| Investing Cash Flow * | $11.4M | -$2.0K | $2.7M | $10.0K | $9.5M | -$6.3M | $3.9M | $15.7M | $11.2M | -$18.1M | -$12.6M | ||||||||||||||||||||||||||||||||||
| Operating Cash Flow * | -$11.1M | -$5.3M | -$8.3M | -$6.8M | -$6.5M | -$4.5M | -$4.9M | -$2.2M | -$11.0K | -$9.1M | -$6.4M | -$1.7M | -$10.7M | -$7.4M | -$4.0M | ||||||||||||||||||||||||||||||
| Share Based Compensation | $2.3M | $2.9M | $2.2M | $1.3M | $1.5M | $1.3M | $1.2M | $1.2M | $1.1M | $829.0K | $840.0K | $823.0K | $530.0K | $621.0K | $542.0K | $281.0K | $308.0K | $302.0K | $310.0K | $317.0K | $290.0K | $210.0K | $197.0K | $181.0K | $152.0K | $212.0K | $211.0K | -$134.0K | $919.0K | $468.0K | $712.0K | $712.0K | $516.0K | $952.0K | $1.0M | $1.0M | $887.0K | $855.0K | $748.0K | $581.0K | $709.0K | $320.0K | $312.0K | $283.0K | $271.0K |
| Increase Decrease In Accounts Payable Trade | -$293.0K | -$245.0K | -$597.0K | -$423.0K | $253.0K | -$675.0K | $550.0K | $207.0K | $149.0K | -$751.0K | $916.0K | $784.0K | -$130.0K | ||||||||||||||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$85.0K | -$92.0K | -$886.0K | $10.0K | -$318.0K | $190.0K | -$88.0K | -$217.0K | -$189.0K | -$401.0K | $842.0K | -$4.0M | -$370.0K | ||||||||||||||||||||||||||||||||
| Increase Decrease In Employee Related Liabilities | -$2.1M | -$1.4M | -$931.0K | -$1.3M | -$952.0K | -$697.0K | -$680.0K | $134.0K | $22.0K | -$523.0K | -$602.0K | -$801.0K | -$848.0K | ||||||||||||||||||||||||||||||||
| Increase Decrease In Lease Obligations | -$1.0K | $1.0K | $58.0K | -$1.0K | $5.0K | $4.0K | -$14.0K | $27.0K | $19.0K | $14.0K | -$124.0K | $30.0K | -$3.0K | ||||||||||||||||||||||||||||||||
| Increase Decrease In Other Accrued Liabilities | $732.0K | $686.0K | $296.0K | $300.0K | -$373.0K | -$130.0K | -$199.0K | $94.0K | $113.0K | $268.0K | -$1.8M | $1.3M | |||||||||||||||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $2.0K | $54.0K | $1.0K | $205.0K | $7.0K | $110.0K | $32.0K | ||||||||||||||||||||||||||||||||||||||
| Increase Decrease In Accounts Receivable | -$8.0K | -$241.0K | $219.0K | -$4.1M | -$47.0K | $4.4M | -$47.0K | $124.0K | |||||||||||||||||||||||||||||||||||||
| Increase Decrease In Accrued Clinical Liabilities | $879.0K | $245.0K | -$366.0K | $870.0K | $1.7M | $184.0K | $887.0K | ||||||||||||||||||||||||||||||||||||||
| Proceeds From Warrant Exercises | $77.0K | $24.0K | $236.0K | $4.2M | |||||||||||||||||||||||||||||||||||||||||
| Increase Decrease In Accrued Liabilities | $887.0K | -$103.0K | -$3.1M | -$1.5M | -$3.8M | $1.3M | $1.9M | ||||||||||||||||||||||||||||||||||||||
| Increase Decrease In Accrued Interest Receivable Net | -$32.0K | -$58.0K | -$42.0K | -$52.0K | -$6.0K | $9.0K | |||||||||||||||||||||||||||||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $19.0K | $52.0K | |||||||||||||||||||||||||||||||||||||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $4.0K | -$1.0K | $2.0K | -$1.0K | -$3.0K | -$2.0K | -$25.0K | ||||||||||||||||||||||||||||||||||||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $9.5M | $17.9M | $3.0M | $15.8M | $19.6M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.25 | -$1.24 | -$1.50 | -$4.00 | -$4.08 | -$5.42 | -$39.76 | -$72.29 | -$22.07 | -$581.25 | -$39.00 | -$1.45 | -$2.17 | -$1.56 | -$1.51 | -$1.79 | -$0.95 |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 75.0M | 75.0M | 75.0M | 50.0M | 25.0M | 25.0M | 25.0M | |
| Common Stock Shares Issued | 53.2M | 34.7M | 21.2M | 17.9M | 9.5M | 6.1M | 1.5M | 6.7M | 1.2M | 21.2K | 29.8M | 22.6M | 14.7M | 14.7M | 14.7M | 9.7M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 8.1M | 2.7M | 412.3K | 175.5K | 479.4K | 2.1K | 21.2K | 18.1M | 14.7M | 13.5M | 9.7M | ||||||
| Common Stock Shares Outstanding | 53.2M | 34.7M | 21.2M | 17.9M | 9.5M | 6.1M | 1.5M | 6.7M | 1.2M | 21.2K | 29.8M | 22.6M | 14.7M | 14.7M | 9.7M | 9.7M | |
| Weighted Average Number Of Shares Outstanding Basic | 43.6M | 32.1M | 19.8M | 10.6M | 8.1M | 2.7M | |||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 43.6M | 32.1M | 19.8M | 10.6M | 8.1M | 2.7M | |||||||||||
| Earnings Per Share Basic | $-1.25 | $-1.24 | $-1.50 | $-4.00 | $-4.08 | $-5.42 | |||||||||||
| Shares Issued On Exercise Of Warrants Value | 1.4M | 682.0K | 227.0K | 24.0K | 338.0K | 3.2M | 4.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.28 | -$0.37 | -$0.37 | -$0.36 | -$0.25 | -$0.26 | -$0.34 | -$0.43 | -$0.50 | -$1.35 | -$1.08 | -$0.80 | -$0.76 | -$0.71 | -$1.53 | -$1.30 | -$1.11 | -$1.14 | -$1.68 | -$2.15 | -$5.91 | -$9.07 | -$10.08 | -$17.57 | -$0.55 | -$0.71 | -$1.82 | -$2.43 | -$3.17 | -$8.95 | -$79.60 | -$96.56 | -$22.89 | -$12.62 | -$11.21 | -$11.40 | $0.06 | $0.16 | $0.26 | $0.20 | -$0.26 | -$0.23 | -$0.47 | -$0.59 | -$0.45 | -$0.68 | -$0.57 | -$0.46 | -$0.28 | $0.40 | -$0.29 | -$0.67 | -$0.45 | $0.67 | $0.31 | $1.07 | -$0.02 |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | ||||||||||||||
| Common Stock Shares Issued | 52.8M | 49.7M | 34.7M | 34.4M | 34.3M | 34.3M | 21.2M | 21.1M | 17.9M | 9.7M | 9.7M | 9.5M | 9.5M | 6.1M | 3.6M | 1.9M | 31.4M | 8.1M | 8.1M | 6.7M | 4.9M | 4.2M | 12.8M | 11.5M | 30.1M | 30.1M | 30.1M | 30.0M | 29.9M | 29.8M | 24.5M | 22.7M | 21.3M | 15.6M | 14.8M | 14.7M | 14.7M | 14.7M | 14.7M | 14.6M | 9.7M | 9.7M | |||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 9.5M | 9.5M | 7.4M | 6.1M | 3.3M | 1.7M | 1.5M | 405.0K | 359.5K | 6.7M | 4.5M | 1.5M | 1.2M | 722.6K | 2.1K | 21.2K | 21.2K | 29.9M | 29.8M | 28.5M | 23.5M | 22.7M | 21.1M | 15.0M | 14.7M | 14.7M | 14.7M | 14.7M | 14.6M | ||||||||||||||||||||||||||||
| Common Stock Shares Outstanding | 52.8M | 49.7M | 34.7M | 34.4M | 34.3M | 34.3M | 21.2M | 21.1M | 17.9M | 9.7M | 9.7M | 9.5M | 9.5M | 6.1M | 3.6M | 1.9M | 31.4M | 8.1M | 8.1M | 6.7M | 4.9M | 4.2M | 12.7M | 11.5M | 30.1M | 30.1M | 30.0M | 30.0M | 29.9M | 29.8M | 24.4M | 22.7M | 21.3M | 15.6M | 14.8M | 14.7M | 14.7M | 14.7M | 14.7M | 14.6M | 14.5M | 9.7M | 9.7M | ||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 51.0M | 34.7M | 34.7M | 34.4M | 34.3M | 25.0M | 21.1M | 19.0M | 17.9M | 9.7M | 9.6M | 9.5M | 9.5M | 7.4M | 14.6M | 9.7M | 9.7M | 6.5M | 6.4M | ||||||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 51.0M | 34.7M | 34.7M | 34.4M | 34.3M | 25.0M | 21.1M | 19.0M | 17.9M | 9.7M | 9.6M | 9.5M | 9.5M | 7.4M | 14.6M | 10.0M | 9.7M | 6.5M | 6.5M | ||||||||||||||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.28 | $-0.37 | $-0.37 | $-0.36 | $-0.25 | $-0.26 | $-0.34 | $-0.43 | $-0.50 | $-1.35 | $-1.08 | $-0.80 | $-0.71 | $-1.53 | $0.40 | $-0.46 | $1.07 | ||||||||||||||||||||||||||||||||||||||||
| Shares Issued On Exercise Of Warrants Value | 120.0K | 150.0K | 77.0K | 24.0K | 8.0K | 95.0K | 236.0K | 2.5M | 589.0K | 4.2M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $54.9M | $39.1M | $27.3M | $40.8M | $33.1M | $14.8M | $16.5M | $12.8M | $6.6M | $1.7M | $36.9M | $56.6M | $65.2M | $46.1M | $27.8M | $28.4M | $28.1M |
| Investment Income Interest | $1.5M | $2.4M | $825.0K | $199.0K | $17.0K | $69.0K | $170.0K | $171.0K | $21.0K | $203.0K | $119.0K | $35.0K | $150.0K | $292.0K | $220.0K | $86.0K | $47.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $8.8M | $5.3M | $3.4M | $3.3M | $2.2M | $1.3M | $1.2M | $1.2M | $348.0K | $1.6M | $2.3M | $3.9M | $2.8M | $2.2M | $1.2M | $642.0K | $380.0K |
| Fair Value Adjustment Of Warrants | -$150.0K | -$873.0K | -$1.9M | -$3.7M | -$3.2M | -$4.5M | -$7.4M | -$96.0K | |||||||||
| Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 1.7M | 113.1K | 139.8K | 26.6K | 231.00 | 236.00 | 256.00 | 5.4K | 546.00 | 0.00 | 269.4K | 203.1K | 47.5K | 0.00 | 0.00 | ||
| Depreciation | $27.0K | $32.0K | $31.0K | $60.0K | $59.0K | $188.0K | $244.0K | $223.0K | $227.0K | $100.0K | $75.0K | $52.0K | $50.0K | ||||
| Depreciation And Amortization | $228.0K | $229.0K | $228.0K | $236.0K | $250.0K | $255.0K | |||||||||||
| Warrants And Rights Outstanding | $1.1M | $3.0M | $214.0K | $3.4M | $7.9M | $15.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $14.7M | $12.6M | $12.9M | $12.5M | $8.4M | $6.0M | $6.6M | $7.7M | $8.6M | $12.6M | $10.1M | $7.2M | $7.1M | $6.7M | $11.3M | $8.0M | $4.7M | $3.8M | $2.9M | $3.4M | $3.2M | $3.7M | $3.7M | $5.9M | $3.7M | $3.3M | $2.8M | $3.0M | $3.8M | $2.4M | $158.0K | $321.0K | $609.0K | $398.0K | $353.0K | $354.0K | $9.5M | $11.4M | $9.6M | $6.4M | $12.3M | $12.0M | $12.6M | $19.7M | $15.6M | $20.5M | $15.7M | $13.4M | $16.0M | $14.9M | $8.4M | $6.8M | $9.2M | $5.3M | $6.9M | $6.4M | $11.8M | $4.6M |
| Investment Income Interest | $554.0K | $192.0K | $322.0K | $673.0K | $833.0K | $368.0K | $262.0K | $193.0K | $162.0K | $73.0K | $4.0K | $4.0K | $3.0K | $3.0K | $8.0K | $2.0K | $3.0K | $42.0K | $40.0K | $41.0K | $62.0K | $61.0K | $17.0K | $10.0K | $9.0K | $23.0K | $27.0K | $53.0K | $61.0K | $48.0K | $24.0K | $13.0K | $54.0K | $3.0K | $4.0K | $12.0K | $33.0K | $39.0K | $52.0K | $86.0K | $91.0K | $50.0K | $49.0K | $63.0K | $56.0K | $25.0K | $14.0K | |||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.3M | $2.9M | $2.2M | $1.3M | $1.5M | $1.3M | $1.2M | $1.2M | $1.1M | $829.0K | $840.0K | $823.0K | $530.0K | $621.0K | $542.0K | $281.0K | $308.0K | $302.0K | $310.0K | $317.0K | $290.0K | $210.0K | $197.0K | $181.0K | ||||||||||||||||||||||||||||||||||
| Fair Value Adjustment Of Warrants | -$111.0K | -$66.0K | -$52.0K | -$621.0K | $533.0K | -$667.0K | -$131.0K | $429.0K | -$465.0K | -$2.9M | -$615.0K | $721.0K | -$539.0K | -$901.0K | -$1.4M | -$2.3M | -$1.6M | $1.4M | -$8.6M | $1.7M | -$2.1M | |||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 0.00 | 113.1K | 0.00 | 139.8K | 26.6K | 26.6K | 231.00 | 0.00 | 236.00 | 0.00 | 0.00 | 256.00 | 6.00 | 133.00 | 5.3K | 0.00 | 0.00 | |||||||||||||||||||||||||||||||||||||||||
| Depreciation | $93.0K | $56.0K | $46.0K | $55.0K | $44.0K | $19.0K | $19.0K | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Depreciation And Amortization | $62.0K | $57.0K | $58.0K | $60.0K | $64.0K | $61.0K | $65.0K | $86.0K | $56.0K | |||||||||||||||||||||||||||||||||||||||||||||||||
| Warrants And Rights Outstanding | $3.0K | $114.0K | $180.0K | $232.0K | $350.0K | $971.0K | $438.0K | $2.8M | $3.0M | $2.5M | $4.0M | $320.0K | $935.0K | $548.0K | $1.1M | $2.0M | $5.4M | $7.7M | $9.3M | $6.2M | $14.8M |
Most recent annual filing with the SEC: March 24, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.